Vergoeding 2018-2022 voor ATC-subgroep N04BC : Dopamine-agonisten
- Raming voor de totale Zvw-populatie
2018 | 2019 | 2020 | 2021 | 2022 | |
---|---|---|---|---|---|
N04BC01 Bromocriptine | 8.474 | 3.039 | 440 | . | . |
N04BC02 Pergolide | 687 | . | . | . | . |
N04BC04 Ropinirol (Requip modutab ®) | 1.719.400 | 1.548.500 | 1.439.900 | 1.128.500 | 1.044.200 |
N04BC05 Pramipexol (Sifrol ®) | 4.789.000 | 4.939.300 | 4.679.900 | 4.495.400 | 4.562.700 |
N04BC07 Apomorfine (Apo-go ®) | 262.870 | 514.010 | 684.610 | 758.300 | 1.068.100 |
N04BC09 Rotigotine (Neupro ®) | 2.401.200 | 2.520.600 | 2.572.500 | 2.573.600 | 2.636.100 |
Totaal | 9.181.631 | 9.525.449 | 9.377.350 | 8.955.800 | 9.311.100 |